| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $295K | — | — |
| Cost of Revenue | $220K | — | — |
| Gross Profit | $75K | — | — |
| R&D Expense | $93K | — | -67.3% |
| SG&A Expense | $18.8M | — | +1184.0% |
| Operating Income | -$19.2M | — | -825.8% |
| Net Income | -$19.3M | +5.8% | -792.2% |
| EPS (Basic) | -$0.54 | — | -575.0% |
| EPS (Diluted) | -$0.54 | — | -575.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $0 | — | — |
| Inventory | $1.4M | — | — |
| Current Assets | $3.0M | — | — |
| Total Assets | $4.6M | — | — |
| Current Liabilities | $4.4M | — | — |
| Total Liabilities | $12.3M | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | — | — |
| Investing Cash Flow | -$657K | — | — |
| Financing Cash Flow | $5.0M | — | — |
| Stockholders' Equity |
| -$7.7M |
| -25.8% |
| -230.6% |